Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
11.74
+0.46 (4.08%)
At close: Jul 26, 2024, 4:00 PM
11.54
-0.20 (-1.70%)
After-hours: Jul 26, 2024, 6:35 PM EDT
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PHAT stock have an average target of 22, with a low estimate of 10 and a high estimate of 28. The average target predicts an increase of 87.39% from the current stock price of 11.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PHAT stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +121.47% | Jul 26, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +121.47% | Jul 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +138.50% | Jul 19, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +121.47% | Jul 19, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +121.47% | Jul 12, 2024 |
Financial Forecast
Revenue This Year
42.65M
from 682.00K
Increased by 6,153.81%
Revenue Next Year
166.93M
from 42.65M
Increased by 291.39%
EPS This Year
-5.36
from -3.93
EPS Next Year
-3.87
from -5.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 51.1M | 249.2M | 515.8M | 721.3M | 909.8M |
| Avg | 42.7M | 166.9M | 363.5M | 523.7M | 720.2M |
| Low | 33.6M | 117.3M | 234.2M | 405.4M | 521.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7,397.8% | 484.3% | 209.0% | 98.4% | 73.7% |
| Avg | 6,153.8% | 291.4% | 117.7% | 44.1% | 37.5% |
| Low | 4,828.7% | 175.1% | 40.3% | 11.5% | -0.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.28 | -3.10 | 0.50 | -1.60 | 0.19 |
| Avg | -5.36 | -3.87 | -1.74 | -1.60 | 0.17 |
| Low | -5.46 | -4.19 | -2.94 | -1.59 | 0.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.